News | EP Lab | September 23, 2015

Societies Release New Guideline for Treating Supraventricular Tachycardia

Includes guidelines for diagnosis, referrals

guideline, treating supraventricular tachycardia, ACC, AHA, HRS

September 23, 2015 — A new guideline aimed at helping clinicians treat patients with supraventricular tachycardia, or a rapid heart rate, was released Sept. 23 by the American College of Cardiology, American Heart Association and Heart Rhythm Society.

Supraventricular tachycardia is common, with a prevalence of 2.29 per 1,000 persons in the general population. Those who have supraventricular tachycardia without any cardiovascular disease are usually younger compared to those who have cardiovascular disease. Women have twice the risk of developing the condition compared to men, and individuals over the age of 65 have five times the risk compared to younger individuals. Supraventricular tachycardia can impact quality of life depending on frequency, duration and whether symptoms occur not only when exercising but also while at rest. 

A diagnosis of supraventricular tachycardia is often made in the emergency department. A 12-lead electrocardiogram during tachycardia and sinus rhythm may help to determine the cause of tachycardia.

“The overall goal of the guideline is to provide clinicians with the tools needed to successfully diagnose and treat patients with supraventricular tachycardia upon presentation in the inpatient or outpatient setting,” said Richard L. Page, M.D., FACC, FAHA, FHRS, chair of the department of medicine at the University of Wisconsin and chair of the writing committee. “This includes quick diagnosis and treatment, making any necessary referrals to cardiology and electrophysiology specialists, discussion and collaboration with the patient, and the prescription of appropriate treatment.”

The guideline also aims to aid clinicians to help patients differentiate between supraventricular tachycardia and other disorders, such as panic attack, chest pain, and shortness of breath and syncope or near syncope— or a loss of consciousness due to a drop in blood pressure— that may cause similar symptoms.

The complete 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia, was jointly published online in the Journal of the American College of Cardiology, Circulation, and HeartRhythm.

It is important to note that while atrial fibrillation is a supraventricular tachycardia, the term does not usually refer to atrial fibrillation. This guideline is for the management of all types of supraventricular tachycardia other than atrial fibrillation. Atrial fibrillation is addressed in the 2014 ACC/AHA/HRS Guideline for the Management of Atrial Fibrillation.

For more information: www.acc.org, www.heart.org, www.hrsonline.org

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init